Image

SL-START - SubLingual Apomorphine Schemes of TitrAtion in Real-world Treatment

SL-START: Testing Sublingual Apomorphine for Real-world Use.

Recruiting
18 years and older
All
Phase N/A
  • Simplified description (AI rewritten)
  • Technical description (Original)

SL-START is a study about using sublingual apomorphine (SL-APO) for treating Parkinson's disease. This medicine helps when patients have "OFF episodes," moments when their regular medication isn't working well. The study is observational, meaning doctors watch and record how the drug is used in real life, but they don’t change how patients are treated.

Participants need to be at least 18 and have Parkinson's. They should not have dementia or be part of another drug study. The study involves checking how patients adjust to the dose of SL-APO, starting with a baseline visit. Patients will use a Patient Titration Diary to record their dose adjustments. This will help doctors understand the right dose for each person. Follow-up visits happen at 3 and 6 months to see how patients are doing and to decide if they should keep taking the medicine.

  • Study lasts 6 months with visits at 3 and 6 months.
  • Participants keep a diary to track medication use.
  • No extra medical procedures are needed beyond normal care.
Print
Study details
    Parkinson Disease

NCT07145190

Bial - Portela C S.A.

15 August 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.